Cough Medicine Ingredient Could Treat Prostate Cancer, Study Shows


By Tuesday, 30 December 2008 19:00

A laboratory study published December 18 in the December issue of the European medical journal Anticancer Research reports that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer. Researchers found that noscapine, which has been used in cough medication for nearly 50 years, in mice reduced tumor growth by 60% and limited the spread of tumors by 65% without causing harmful side effects.

Noscapine is approved for use in some countries as a cough suppressant or available as an over the counter cough medicine, and Dr. Barken has prescribed it "off-label" to patients with prostate cancer.

However, patients who have taken noscapine in an effort to control prostate cancer do not appear to have benefited so far. 

Read more: Cough Medicine Ingredient Could Treat Prostate Cancer, Study Shows


Cancer Vaccine Plus Interleukin-7 Boosts Immune Response to Cancer



Sunday, 26 April 2009 08:00

Scientists have discovered that combining interleukin-7 (IL-7) – a key component of the immune system – with a viral vaccine improves the ability of the immune system to attack tumors. A Canadian team at The Campbell Family Institute for Breast Cancer Research (CFIBCR) at Princess Margaret Hospital, Toronto say their discovery could be included in new clinical trials that use a patient’s own cells to destroy tumors.

Read more ....


Bone Pain Control Using MRI and Ultrasound


Saturday, 15 November 2008 08:49

Magnetic resonance-guided focused ultrasound surgery (MRgFUS), a noninvasive thermal ablation technique that has been shown to be clinically effective in the treatment of uterine fibroids, is now being evaluated as a method for treating painful bone metastases.

Now physicians in North America are running a full scale clinical trial to see if the method really does work as well or better than traditional pain management methods.

Read more: Bone Pain Control Using MRI and Ultrasound


First Gene Marker Found for Aggressive Prostate Cancer


Aggressive PCa - Genetic Risk Factors

Tuesday, 12 January 2010 12:25

A genetic variant associated with aggressive prostate cancer has been discovered by researchers at Wake Forest University Baptist Medical Center. Claiming their discovery as a "first," the  scientists say  that one day genetic information may be used in combination with other factors to guide treatment decisions.

Read more . . .


Minority Patients Prefer Empowering Cancer Messages


Equal Cancer Care - African American

Wednesday, 29 October 2008 19:00

Harping on negative consequences of a lack of cancer screening among minorities can actually make African-Americans less likely to go for screening, according to behavioral science research published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Read more: Minority Patients Prefer Empowering Cancer Messages


Page 1 of 9